Altria Group, Inc.

NYSE•MO

CEO: Mr. William F. Gifford Jr.

セクター: Consumer Defensive

業種: Tobacco

上場日: 1985-07-01

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand. It sells its products to distributors, as well as large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.

連絡先情報

6601 West Broad Street, Richmond, VA, 23230, United States

804-274-2200

www.altria.com

時価総額

$108.57B

PER (TTM)

15.7

18.5

配当利回り

6.5%

52週高値

$70.51

52週安値

$54.70

52週レンジ

65%

順位13Top 2.2%

6.8

F-Score

改良版 Piotroski 分析

10年ファンダメンタル

強い • 6.8 / 9 ポイント

スコアレンジ (0-9)

8-9: 価値が優れている

6-7: 基礎体質が強い

4-5: 全体的に堅調

0-3: パフォーマンスが弱い

データ期間: 2016-2025

財務ダッシュボード

Q4 2025 データ

売上高

$5.85B+14.49%

直近4四半期の推移

EPS

$0.66-63.33%

直近4四半期の推移

フリーCF

$3.18B-3.46%

直近4四半期の推移

2025 Annual 決算ハイライト

主なハイライト

Adjusted Earnings Growth Adjusted Net Earnings grew 2.4% to $9.15B USD; Adjusted Diluted EPS increased 4.4% to $5.42 USD.

Cigarette Volume Decline Total cigarette shipments fell 10.0% to 61.8B units in 2025, driven by down-trading pressures.

Major E-Vapor Impairments Recorded $2.13B in asset impairment charges, including $1.16B goodwill impairment for e-vapor unit.

Share Repurchase Activity Repurchased $1.0B common stock during Q4 2025 under the January 2025 program authorization.

リスク要因

Illicit E-Vapor Competition Illicit flavored disposable e-vapor products continue to drive cigarette volume decline and challenge growth.

E-Vapor Asset Devaluation E-vapor reporting unit goodwill impaired by $1.16B due to protracted enforcement against illicit flavored products.

Tobacco Litigation Uncertainty Ongoing tobacco and health litigation remains subject to uncertainty, potentially resulting in material adverse effects.

Premium Brand Down-trading Macroeconomic pressures caused consumers to reduce consumption and purchase lower-priced discount brands.

見通し

2028 EPS Growth Target Targeting mid-single digit adjusted diluted EPS CAGR by 2028 from a $4.87 base in 2022.

Optimize & Accelerate Savings Initiative expects to deliver cumulative savings of at least $600M by the end of fiscal year 2029.

Progressive Dividend Goal Maintain progressive dividend goal targeting mid-single digits dividend per share growth annually through 2028.

Smoke-Free Portfolio Focus Remain committed to building FDA-authorized smoke-free product portfolio beyond current nicotine categories.

同業比較

売上高 (TTM)

$123.01B

-7.0%

TGT

$105.64B

-1.4%

BUD

$88.26B

-1.2%

粗利益率 (最新四半期)

100.0%

+0.0pp

BTI

83.4%

+1.1pp

62.1%

-8.5pp

主要指標

銘柄コード	時価総額	PER (TTM)	ROE (TTM)	負債比率
BUD	$146.35B	21.9	8.2%	33.4%
UL	$125.17B	24.4	26.0%	42.0%
BTI	$121.94B	11.7	16.3%	32.1%

長期トレンド

直近4四半期

売上高

純利益

営業キャッシュフロー

4四半期売上高CAGR

9.0%

安定成長

4四半期純利益CAGR

1.2%

収益性の緩やかな改善

キャッシュフロー安定性

100%

優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年4月27日

EPS:-

売上高:-

財務データ

決算説明会

財務レポート

ニュース

損益計算書

バランスシート

キャッシュフロー計算書

財務比率

変化率

損益計算書	直近12ヶ月

データなし